EuropaBio Annual Report is now available
If you want us to send you a hard copy of the report please complete the following on-line request:
http://www.europabio.org/form-AR2004.htm
Full report can be downloaded from:
http://www.europabio.org/documents/Brochure%20Annual%20Report%202005_FINAL.pdf



EuropaBio hosts Policy briefing on BioImpact with patients and EU Commission on July 12th
A special policy briefing will be organised July 12 with the EU Commission to present the benefits of healthcare biotech innovation and impact on quality of life. www.bioimpact.org



Plants for the Future: Announcing a Strategic Research Agenda for European Research in Plant Genomics and Biotechnology
On 5^th July EuropaBio coannounced during a Press conference held in Strasbourg, the new research agenda for the European Technology Platform “Plants for the future”.
Live web cast of the event including all information, presentations and background documents from the event at:
http://www.europabio.org/ne_SRAGreen.htm


 
EuropaBio publishes position on new Advanced Therapies
EuropaBio responded to the Commission’s consultation on Advanced Therapies (including human cell and tissue engineered products).  The position largely welcomes the Commission proposal to use the pharma rules and aligns both the Medical Device and the pharma associations together.  For more information please contact:
Aurélie Vandeputte a.vandeputte@europabio.org
Commission Advanced Therapies web site
http://pharmacos.eudra.org/F2/advtherapies/index.htm

EP delays vote on Regulation on Medicinal Products for Paediatric Use
The vote is now expected in the Environment Committee on July 13^th and will go to a plenary vote in September. EuropaBio along with its 25 National Associations has submitted a strong position to Parliament and backs the pharma industry’s position.
http://www.members.europabio.org/Positions/Paediatrics0605.pdf

 

Member States Refuse to Lift Illegal Bans on GM Products
The EU Environment Council voted against all Commission proposals to lift bans or restrictions (so-called national safeguard clauses) imposed by Austria, France, Germany, Greece and Luxembourg on 8 authorised GM products. This is the first time that Council found a qualified majority against a Commission proposal on GMOs.
EuropaBio Press release:
http://www.europabio.org/articles/Vote%20to%20keep%20ban_050624.doc
European Commission press release:
http://europa.eu.int/rapid/pressReleasesAction.do?reference=IP/05/793&format=HTML&aged=0&language=EN&guiLanguage=en

European Commission high-profile conference on Knowledge-based bio-economy
In recognition of the growing importance of the emerging knowledge-based sector of the bio-economy, the European Commission is to hold a high-profile conference in Brussels (Belgium) on 15 and 16 September to chart a course towards a modern knowledge-based bio-economy. EuropaBio highly recommends active participation of the biotech sector and companies in this conference.
For further information, please consult the following web address:
http://europa.eu.int/comm/research//conferences/2005/kbb/index_en.html


 
EuropaBio publishes Strategic Research Agenda for Industrial Biotech
The document is now in public consultation as part of the Sustainable Chemistry Technology Platform. www.suschem.org
http://www.europabio.org/TPWhite/IB%20SRA_130605.doc  

The European Commission launched the European Technology Platform "Food for Life"
The European Technology Platform "Food for Life" was launched the 5th of July. The consultation process will start with the aim of developing a Strategic Research Agenda and an associated Implementation Plan.
All information, including the Vision Paper, can be found at:
http://212.123.1.64/etpciaaadmin/asp/home.asp



EuropaBio publishes position on “The scope of the EU GM Food & Feed Regulation (EC) 1829/ 2003”
http://www.europabio.org/positions/scope%20food&feed%20pospaper.pdf



Commission may unveil special Young Innovative Company (YIC) definition soon
A new definition would mean that young research based companies like biotech firms that meet this new definition could qualify for special tax exemptions or special services.  EuropaBio has lobbied hard to obtain an EU-wide YIC-definition; rumours are that Commission plans to publish the proposal for consultation at the end of next month.



EU research budget threatened
After the June summit failed to reach agreement on the overall budget for the EU for the next 7 years – no money can be allocated to any of the Union’s policies. That means that the Commission’s proposed EUR 70 billion for research is not certain to be agreed, in fact the Luxembourg presidency proposed a cut of 30% to try to get a last minute agreement.  We have everything to fight for and must continue to put pressure on member states so that they do not sacrifice research in order to maintain other forms of aid.



A Special Effort to Support Research Intensive SMEs in Health/Biotechnology Sectors – 4^th call SMEs
A special effort to stimulate the participation of small and medium-sized enterprises1, SMEs, in Thematic Priority 1 in the 4th call for proposals is done by introducing the Specific Targeted Research Projects (STREPs) dedicated to SMEs,“SME-STREPs”.
http://www.europabio.org/documents/4callSMEsleaflet.pdf

Obtaining a contract with the EC for an FP6 Project
A successful consultant with two FP6 contracts for integrated projects accepted in Life Sciences, highly qualified and knowledgeable in all aspects of FP6 criteria and hurdles, presently project manager of an IP, offers his services to companies and other organisations participating  or interested in participating, in FP6. Missions for IP's,' NoE's, STREP's,... may include i.a. proposal preparation and submission, contract negotiation, consortium agreement if required, SME opportunities, project management, advice on FP6 management/financial conditions, contact person with the Commission,.... Based in a Brussels suburb. Please send e-mail to David Muntz, Ir, MBA, at dmuntz@skynet.be or call on +32 475 79 49 61.
 
 

18 -20 October - BIOTECHNICA 2005 - International Trade Fair for Biotechnology, Hannover, Germany
Most important biotechnology exposition in Europe with about 1.000 exhibitors and 13.000 visitors from 25 countries. Fields of applications: Pharmaceuticals/Medicine, Environment, Agriculture, Food/Nutrition, Bioinformatics, Services, Equipment . http://www.biotechnica.de

25-27 October 2005 – Sixth Workshop on Partnering for Rare Disease Therapy Development, London, UK
This high level workshop will bring together representatives from key stakeholder groups –  patients, regulators, charities, the academic and clinical community, industry and health care providers – from across Europe and North America and from the rest of the world. For more information or to register go to: www.epposi.org.

28 – 30 November 2005 - European Biotech Crossroads, Lille, France
The 2005 edition will offer the biotechnology community a unique occasion to share new scientific knowledge, foster innovation, gather funding and seize new market opportunities. http://www.europeanbiotechcrossroads.com

If you do not want to receive this information again, please click here

If you have any questions, comments or suggestions please send a message to: a.cornea@europabio.org

All password protected documents are available to EuropaBio members only. If you want to become a EuropaBio member please visit the EuropaBio membership page at: http://www.europabio.org/eu_join.htm